122 related articles for article (PubMed ID: 2126534)
21. Paramagnetic dextrans as magnetic resonance blood pool tracers.
Meyer D; Schaefer M; Chambon C; Beaute S
Invest Radiol; 1994 Jun; 29 Suppl 2():S90-2. PubMed ID: 7523330
[No Abstract] [Full Text] [Related]
22. Synthesis and in vivo evaluation of new contrast agents for cardiac MRI.
Saab-Ismail NH; Simor T; Gaszner B; Lóránd T; Szöllösy M; Elgavish GA
J Med Chem; 1999 Jul; 42(15):2852-61. PubMed ID: 10425094
[TBL] [Abstract][Full Text] [Related]
23. [Artificial contrasting during magnetic resonance tomography].
Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
[No Abstract] [Full Text] [Related]
24. Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging.
Kabalka GW; Davis MA; Buonocore E; Hubner K; Holmberg E; Huang L
Invest Radiol; 1990 Sep; 25 Suppl 1():S63-4. PubMed ID: 2283259
[No Abstract] [Full Text] [Related]
25. Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
Sze G; Brant-Zawadzki M; McNamara MT; Haughton VM; Kumar AJ; Maravilla KR; Aisen AM; Dreisbach JN; Bradley WG; Weinreb JC
Invest Radiol; 1993 Mar; 28 Suppl 1():S49-55. PubMed ID: 8486504
[TBL] [Abstract][Full Text] [Related]
26. Coordination chemistry of amide-functionalised tetraazamacrocycles: structural, relaxometric and cytotoxicity studies.
Martinelli J; Balali-Mood B; Panizzo R; Lythgoe MF; White AJ; Ferretti P; Steinke JH; Vilar R
Dalton Trans; 2010 Nov; 39(42):10056-67. PubMed ID: 20877892
[TBL] [Abstract][Full Text] [Related]
27. Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent.
Van Wagoner M; Worah D
Invest Radiol; 1993 Mar; 28 Suppl 1():S44-8. PubMed ID: 8486503
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
[TBL] [Abstract][Full Text] [Related]
29. Paramagnetic liposomes as magnetic resonance contrast agents.
Unger E; Tilcock C; Ahkong QF; Fritz T
Invest Radiol; 1990 Sep; 25 Suppl 1():S65-6. PubMed ID: 2283260
[No Abstract] [Full Text] [Related]
30. Metal ion release from paramagnetic chelates: what is tolerable?
Rocklage SM; Worah D; Kim SH
Magn Reson Med; 1991 Dec; 22(2):216-21; discussion 229-32. PubMed ID: 1812349
[TBL] [Abstract][Full Text] [Related]
31. [Preclinical toxicological evaluation of Pentamang and Mangascan].
Churin AA; Karpova GV; Fomina TI; Vetoshkina TV; Dubskaia TIu; Voronova OL; Filimonov VD; Belianin ML; Usov VIu
Eksp Klin Farmakol; 2008; 71(4):49-52. PubMed ID: 18819441
[TBL] [Abstract][Full Text] [Related]
32. Theory of paramagnetic contrast agents in liposome systems.
Barsky D; Pütz B; Schulten K; Magin RL
Magn Reson Med; 1992 Mar; 24(1):1-13. PubMed ID: 1313522
[TBL] [Abstract][Full Text] [Related]
33. Block co-polymeric magnetic resonance contrast agents.
Shen D; Fritz T; Wu GL; Kulik B; Palestrant D; Unger E
Invest Radiol; 1994 Jun; 29 Suppl 2():S217-9. PubMed ID: 7928236
[No Abstract] [Full Text] [Related]
34. Reaction of gadolinium chelates with ozone and hydroxyl radicals.
Cyris M; Knolle W; Richard J; Dopp E; von Sonntag C; Schmidt TC
Environ Sci Technol; 2013 Sep; 47(17):9942-9. PubMed ID: 23888885
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of a paramagnetic sialic acid conjugate as probe for magnetic resonance applications.
Bini D; Gregori M; Cosentino U; Moro G; Canales A; Capitoli A; Jiménez-Barbero J; Cipolla L
Carbohydr Res; 2012 Jun; 354():21-31. PubMed ID: 22542576
[TBL] [Abstract][Full Text] [Related]
36. Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd(III) complexes.
Doble DM; Botta M; Wang J; Aime S; Barge A; Raymond KN
J Am Chem Soc; 2001 Oct; 123(43):10758-9. PubMed ID: 11674017
[No Abstract] [Full Text] [Related]
37. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
38. Development of contrast media for magnetic resonance imaging.
Goldstein HA; Wiggins JR; Kashanian F
Ann N Y Acad Sci; 1992 Mar; 649():322-31. PubMed ID: 1580503
[No Abstract] [Full Text] [Related]
39. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
40. 1H and 13C spectral assignments of an oxytocin-DTPA derivative, a ligand for potential receptor-specific MRI contrast agents.
Calabi L; Biondi L; De Miranda M; Ghelli S; Mora C; Paleari L; Rebaudengo C; Umbelli C
Magn Reson Chem; 2005 Aug; 43(8):654-7. PubMed ID: 15986497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
